Systemic iron homeostasis.
暂无分享,去创建一个
[1] M. Cappellini,et al. A hepcidin lowering agent mobilizes iron for incorporation into red blood cells in an adenine-induced kidney disease model of anemia in rats. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[2] M. Muckenthaler,et al. Iron refractory iron deficiency anemia , 2013, Haematologica.
[3] S. Sell,et al. The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys. , 2013, Blood.
[4] D. Swinkels,et al. Randomized double-blind placebo-controlled PK/PD study on the effects of a single intravenous dose of the anti-hepcidin Spiegelmer NOX-H94 on serum iron during experimental human endotoxemia , 2013, Critical Care.
[5] R. Damoiseaux,et al. High-Throughput Screening of Small Molecules Identifies Hepcidin Antagonists , 2013, Molecular Pharmacology.
[6] S. Milstein,et al. An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia. , 2013, Blood.
[7] L. Silengo,et al. Cell-specific regulation of Ferroportin transcription following experimentally-induced acute anemia in mice. , 2013, Blood cells, molecules & diseases.
[8] R. Simpson,et al. Regulation of iron metabolism in Hamp−/− mice in response to iron-deficient diet , 2013, European Journal of Nutrition.
[9] D. Girelli,et al. Serum levels of the hepcidin-20 isoform in a large general population: The Val Borbera study☆ , 2012, Journal of proteomics.
[10] V. Haase,et al. Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis. , 2012, The Journal of clinical investigation.
[11] G. Merlo,et al. The mitochondrial heme exporter FLVCR1b mediates erythroid differentiation. , 2012, The Journal of clinical investigation.
[12] D. Swinkels,et al. Single and Repeated Dose First-in-Human Study with the Anti-Hepcidin Spiegelmer Nox-H94. , 2012 .
[13] A. Prentice,et al. Hepcidin and the Iron-Infection Axis , 2012, Science.
[14] M. Arno,et al. Duodenal reductase activity and spleen iron stores are reduced and erythropoiesis is abnormal in Dcytb knockout mice exposed to hypoxic conditions. , 2012, The Journal of nutrition.
[15] M. Hentze,et al. The hemochromatosis proteins HFE, TfR2, and HJV form a membrane-associated protein complex for hepcidin regulation. , 2012, Journal of hepatology.
[16] T. Ganz,et al. Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis. , 2012, Blood.
[17] Herbert Y. Lin,et al. Repulsive Guidance Molecule (RGM) Family Proteins Exhibit Differential Binding Kinetics for Bone Morphogenetic Proteins (BMPs) , 2012, PloS one.
[18] M. Omary,et al. The Hypoxia-Inducible Factor–C/EBPα Axis Controls Ethanol-Mediated Hepcidin Repression , 2012, Molecular and Cellular Biology.
[19] M. Desjardins,et al. Subcellular Localization of Iron and Heme Metabolism Related Proteins at Early Stages of Erythrophagocytosis , 2012, PloS one.
[20] T. Ganz,et al. Induction of activin B by inflammatory stimuli up-regulates expression of the iron-regulatory peptide hepcidin through Smad1/5/8 signaling. , 2012, Blood.
[21] T. Ganz,et al. Inhibition of hepcidin transcription by growth factors , 2012, Hepatology.
[22] M. Baumann,et al. Binding of hepcidin to plasma proteins. , 2012, Clinical chemistry.
[23] A. Shawki,et al. Substrate Profile and Metal-ion Selectivity of Human Divalent Metal-ion Transporter-1* , 2012, The Journal of Biological Chemistry.
[24] A. Waheed,et al. Ferritin upregulates hepatic expression of bone morphogenetic protein 6 and hepcidin in mice. , 2012, American journal of physiology. Gastrointestinal and liver physiology.
[25] T. Ganz,et al. Molecular mechanism of hepcidin-mediated ferroportin internalization requires ferroportin lysines, not tyrosines or JAK-STAT. , 2012, Cell metabolism.
[26] E. Fung,et al. Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination. , 2012, Cell metabolism.
[27] M. Fleming,et al. Transgenic HFE‐dependent induction of hepcidin in mice does not require transferrin receptor‐2 , 2012, American journal of hematology.
[28] C. Peyssonnaux,et al. Hepatic hypoxia-inducible factor-2 down-regulates hepcidin expression in mice through an erythropoietin-mediated increase in erythropoiesis , 2012, Haematologica.
[29] M. Lidonnici,et al. Deletion of TMPRSS6 attenuates the phenotype in a mouse model of β-thalassemia. , 2012, Blood.
[30] M. Cappellini,et al. Iron overload in non-transfusion-dependent thalassemia: a clinical perspective. , 2012, Blood reviews.
[31] K. Pantopoulos,et al. Regulation of iron transport and the role of transferrin. , 2012, Biochimica et biophysica acta.
[32] Elizabeth C. Theil,et al. Absorption of iron from ferritin is independent of heme iron and ferrous salts in women and rat intestinal segments. , 2012, The Journal of nutrition.
[33] P. Brissot,et al. Non-transferrin bound iron: a key role in iron overload and iron toxicity. , 2012, Biochimica et biophysica acta.
[34] T. Bartnikas. Known and potential roles of transferrin in iron biology , 2012, BioMetals.
[35] Bryan D. Maliken,et al. H(+)-coupled divalent metal-ion transporter-1: functional properties, physiological roles and therapeutics. , 2012, Current topics in membranes.
[36] K. Nakao,et al. A case of congenital dyserythropoietic anemia type 1 in a Japanese adult with a CDAN1 gene mutation and an inappropriately low serum hepcidin-25 level. , 2012, Internal medicine.
[37] J. Kwiatkowski. Real-world use of iron chelators. , 2011, Hematology. American Society of Hematology. Education Program.
[38] T. Ganz,et al. The hepcidin-ferroportin system as a therapeutic target in anemias and iron overload disorders. , 2011, Hematology. American Society of Hematology. Education Program.
[39] Elizabeta Nemeth,et al. Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload. , 2011, The Journal of clinical investigation.
[40] P. Brissot,et al. Iron disorders of genetic origin: a changing world. , 2011, Trends in molecular medicine.
[41] L. Audoly,et al. Discovery and Preclinical Characterization of a Novel Hepcidin Antagonist with Tunable PK/PD Properties for the Treatment of Anemia in Different Patient Populations , 2011 .
[42] Shuling Guo,et al. Target TMPRSS6 for the Treatment of Hereditary Hemochromatosis , 2011 .
[43] B. Bettencourt,et al. Targeting the Hepcidin Pathway with RNAi Therapeutics for the Treatment of Anemia , 2011 .
[44] C. Hong,et al. Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats. , 2011, Blood.
[45] M. Fleming,et al. Perturbation of hepcidin expression by BMP type I receptor deletion induces iron overload in mice. , 2011, Blood.
[46] A. Townsend,et al. Hepcidin regulation by innate immune and infectious stimuli. , 2011, Blood.
[47] G. H. Gudmundsson,et al. Antimicrobial peptides important in innate immunity , 2011, The FEBS journal.
[48] R. Cousins,et al. Zip14 is a complex broad-scope metal-ion transporter whose functional properties support roles in the cellular uptake of zinc and nontransferrin-bound iron. , 2011, American journal of physiology. Cell physiology.
[49] A. Pietrangelo,et al. Non-HFE Hepatic Iron Overload , 2011, Seminars in liver disease.
[50] J. Olynyk,et al. Natural history and management of HFE-hemochromatosis. , 2011, Seminars in liver disease.
[51] L. Silvestri,et al. Low hepcidin accounts for the proinflammatory status associated with iron deficiency. , 2011, Blood.
[52] Paolo Ventura,et al. Serum and liver iron differently regulate the bone morphogenetic protein 6 (BMP6)‐SMAD signaling pathway in mice , 2011, Hepatology.
[53] N. Andrews,et al. Skeletal muscle hemojuvelin is dispensable for systemic iron homeostasis. , 2011, Blood.
[54] F. Gonzalez,et al. Hypoxia-inducible factor-2α mediates the adaptive increase of intestinal ferroportin during iron deficiency in mice. , 2011, Gastroenterology.
[55] C. Newbold,et al. Host-mediated regulation of superinfection in malaria , 2011, Nature Medicine.
[56] D. Scadden,et al. Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation. , 2011, Blood.
[57] Tomas Ganz,et al. Hepcidin and iron regulation, 10 years later. , 2011, Blood.
[58] K. Schwarz,et al. Growth differentiation factor 15 in patients with congenital dyserythropoietic anaemia (CDA) type II , 2011, Journal of molecular medicine.
[59] T. Ganz,et al. Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice , 2011, Hepatology.
[60] G. Shull,et al. Intestinal brush‐border Na+/H+ exchangers are required for iron homeostasis in the mouse , 2011 .
[61] D. Girelli,et al. A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis , 2011, Haematologica.
[62] D. Craik,et al. Understanding the structure/activity relationships of the iron regulatory peptide hepcidin. , 2011, Chemistry & biology.
[63] C. Geissler,et al. Iron, Meat and Health , 2011, Nutrients.
[64] Lyora A. Cohen,et al. A possible role for secreted ferritin in tissue iron distribution , 2011, Journal of Neural Transmission.
[65] H. Tsukamoto,et al. Suppression of hepatic hepcidin expression in response to acute iron deprivation is associated with an increase of matriptase-2 protein. , 2011, Blood.
[66] C. Camaschella,et al. Inherited disorders of iron metabolism , 2011, Current opinion in pediatrics.
[67] D. Girelli,et al. Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo. , 2011, Blood.
[68] N. Andrews,et al. Transferrin is a major determinant of hepcidin expression in hypotransferrinemic mice. , 2011, Blood.
[69] N. Andrews,et al. Tmprss6 is a genetic modifier of the Hfe-hemochromatosis phenotype in mice. , 2009, Blood.
[70] Atlanta,et al. Fatal laboratory-acquired infection with an attenuated Yersinia pestis Strain--Chicago, Illinois, 2009. , 2011, MMWR. Morbidity and mortality weekly report.
[71] T. Ganz,et al. Detection, evaluation, and management of iron-restricted erythropoiesis. , 2010, Blood.
[72] S. Rivella,et al. Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice. , 2010, The Journal of clinical investigation.
[73] K. Yoshizaki,et al. Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease. , 2010, Blood.
[74] Elizabeta Nemeth,et al. In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2. , 2010, Blood.
[75] Wolfgang Vogel,et al. Ferroportin disease: A systematic meta-analysis of clinical and molecular findings☆ , 2010, Journal of hepatology.
[76] S. Vukicevic,et al. BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in Hfe knockout mice. , 2010, Gastroenterology.
[77] T. Arvedson,et al. Serum hepcidin but not prohepcidin may be an effective marker for anemia of inflammation (AI). , 2010, Blood cells, molecules & diseases.
[78] L. Kühn,et al. Intestinal ferritin H is required for an accurate control of iron absorption. , 2010, Cell metabolism.
[79] M. Hentze,et al. Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway. , 2010, Blood.
[80] F. Canonne-Hergaux,et al. Lipid raft-dependent endocytosis: a new route for hepcidin-mediated regulation of ferroportin in macrophages , 2010, Haematologica.
[81] Matthias W. Hentze,et al. Two to Tango: Regulation of Mammalian Iron Metabolism , 2010, Cell.
[82] Dean Y. Li,et al. Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. , 2010, The Journal of clinical investigation.
[83] Y. T. Lee,et al. Expression of growth differentiation factor 15 is not elevated in individuals with iron deficiency secondary to volunteer blood donation , 2010, Transfusion.
[84] D. Swinkels,et al. Increased serum hepcidin and alterations in blood iron parameters associated with asymptomatic P. falciparum and P. vivax malaria , 2010, Haematologica.
[85] D. Kosman. Redox Cycling in Iron Uptake, Efflux, and Trafficking* , 2010, The Journal of Biological Chemistry.
[86] T. Ganz,et al. Reduction of serum hepcidin by hemodialysis in pediatric and adult patients. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[87] N. Andrews,et al. Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis. , 2010, Blood.
[88] I. Egli,et al. Iron bioavailability and dietary reference values. , 2010, The American journal of clinical nutrition.
[89] C. Begley,et al. Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia. , 2010, Blood.
[90] L. Mei,et al. Neogenin inhibits HJV secretion and regulates BMP-induced hepcidin expression and iron homeostasis. , 2010, Blood.
[91] D. Koeberl,et al. The Role of Hepatocyte Hemojuvelin in the Regulation of Bone Morphogenic Protein-6 and Hepcidin Expression in Vivo* , 2010, The Journal of Biological Chemistry.
[92] T. Ganz,et al. Functional expression in Xenopus oocytes reveals that human ferroportin is an iron exporter shared with zinc , 2010 .
[93] S. Vaulont,et al. Hepcidin targets ferroportin for degradation in hepatocytes , 2010, Haematologica.
[94] Guangjun Nie,et al. Both Nramp1 and DMT1 are necessary for efficient macrophage iron recycling. , 2009, Experimental hematology.
[95] M. Hashizume,et al. Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production , 2010, Rheumatology International.
[96] 렁 돈미엔느든문,et al. Anti-ferroportin 1 monoclonal antibodies and uses thereof , 2009 .
[97] G. Anderson,et al. Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload , 2009, Hepatology.
[98] Elizabeth C. Theil. Mining ferritin iron: 2 pathways. , 2009, Blood.
[99] D. Girelli,et al. Reduced serum hepcidin levels in patients with chronic hepatitis C. , 2009, Journal of hepatology.
[100] J. Barton,et al. Hemochromatosis and Vibrio vulnificus Wound Infections , 2009, Journal of clinical gastroenterology.
[101] A. Iolascon,et al. Mutations in the gene encoding DMT1: clinical presentation and treatment. , 2009, Seminars in hematology.
[102] D. English,et al. A novel association between a SNP in CYBRD1 and serum ferritin levels in a cohort study of HFE hereditary haemochromatosis , 2009, British journal of haematology.
[103] C. Beaumont,et al. Not all DMT1 mutations lead to iron overload. , 2009, Blood cells, molecules & diseases.
[104] R. Kaufman,et al. ER Stress Controls Iron Metabolism Through Induction of Hepcidin , 2009, Science.
[105] F. Carvalho,et al. ER Stress-Inducible Factor CHOP Affects the Expression of Hepcidin by Modulating C/EBPalpha Activity , 2009, PloS one.
[106] T. Ganz,et al. The molecular basis of hepcidin-resistant hereditary hemochromatosis. , 2009, Blood.
[107] T. Ganz,et al. Hereditary hemochromatosis due to resistance to hepcidin: high hepcidin concentrations in a family with C326S ferroportin mutation. , 2009, Blood.
[108] H. Tsukamoto,et al. Hemojuvelin-Neogenin Interaction Is Required for Bone Morphogenic Protein-4-induced Hepcidin Expression* , 2009, The Journal of Biological Chemistry.
[109] L. Poppe,et al. Hepcidin Revisited, Disulfide Connectivity, Dynamics, and Structure , 2009, The Journal of Biological Chemistry.
[110] P. Kuchel,et al. Hepcidin, the hormone of iron metabolism, is bound specifically to alpha-2-macroglobulin in blood. , 2009, Blood.
[111] Y. Takei,et al. Impaired regulation of serum hepcidin during phlebotomy in patients with chronic hepatitis C , 2009, Hepatology research : the official journal of the Japan Society of Hepatology.
[112] A. Nissenson,et al. Hepcidin--a potential novel biomarker for iron status in chronic kidney disease. , 2009, Clinical journal of the American Society of Nephrology : CJASN.
[113] C. Datz,et al. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. , 2009, Blood.
[114] T. Rouault,et al. A ferroportin transcript that lacks an iron-responsive element enables duodenal and erythroid precursor cells to evade translational repression. , 2009, Cell metabolism.
[115] B. Andriopoulos,et al. Nramp1 promotes efficient macrophage recycling of iron following erythrophagocytosis in vivo , 2009, Proceedings of the National Academy of Sciences.
[116] D. Harrison-Findik. Is the iron regulatory hormone hepcidin a risk factor for alcoholic liver disease? , 2009, World journal of gastroenterology.
[117] M. Roth,et al. Lack of the bone morphogenetic protein BMP6 induces massive iron overload , 2009, Nature Genetics.
[118] Yin Xia,et al. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism , 2009, Nature Genetics.
[119] D. Rees,et al. Investigation of the biophysical and cell biological properties of ferroportin, a multipass integral membrane protein iron exporter. , 2009, Journal of molecular biology.
[120] Matthias W. Hentze,et al. Bone morphogenetic protein (BMP)-responsive elements located in the proximal and distal hepcidin promoter are critical for its response to HJV/BMP/SMAD , 2009, Journal of Molecular Medicine.
[121] F. Gonzalez,et al. Intestinal hypoxia-inducible transcription factors are essential for iron absorption following iron deficiency. , 2009, Cell metabolism.
[122] Ernest Beutler,et al. Two BMP responsive elements, STAT, and bZIP/HNF4/COUP motifs of the hepcidin promoter are critical for BMP, SMAD1, and HJV responsiveness. , 2009, Blood.
[123] D. Swinkels,et al. Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I. , 2008, Blood.
[124] Jerry Kaplan,et al. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. , 2008, Cell metabolism.
[125] A. Mckie. The role of Dcytb in iron metabolism: an update. , 2008, Biochemical Society transactions.
[126] D. Girelli,et al. Immunoassay for human serum hepcidin. , 2008, Blood.
[127] M. Cazzola,et al. A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron , 2008, Haematologica.
[128] C. López-Otín,et al. Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis. , 2008, Blood.
[129] Jean Mosser,et al. Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver. , 2008, Blood.
[130] P. Ponka,et al. Nramp1 equips macrophages for efficient iron recycling. , 2008, Experimental hematology.
[131] M. Hentze,et al. Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network. , 2008, Annual review of nutrition.
[132] P. Brissot,et al. Current approach to hemochromatosis. , 2008, Blood reviews.
[133] B. Paw,et al. Haem homeostasis is regulated by the conserved and concerted functions of HRG-1 proteins , 2008, Nature.
[134] T. Ganz,et al. Involvement of Hepcidin in the Anemia of Multiple Myeloma , 2008, Clinical Cancer Research.
[135] Lisa A. Lambert,et al. Molecular evolution and characterization of hepcidin gene products in vertebrates. , 2008, Gene.
[136] T. Stemmler,et al. A Cytosolic Iron Chaperone That Delivers Iron to Ferritin , 2008, Science.
[137] B. Beutler,et al. The Serine Protease TMPRSS6 Is Required to Sense Iron Deficiency , 2008, Science.
[138] R. Chung,et al. Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin. , 2008, Blood.
[139] N. Andrews,et al. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA) , 2008, Nature Genetics.
[140] A. Townsend,et al. Ferroportin: lack of evidence for multimers. , 2008, Blood cells, molecules & diseases.
[141] Matthias W. Hentze,et al. A bone morphogenetic protein (BMP)-responsive element in the hepcidin promoter controls HFE2-mediated hepatic hepcidin expression and its response to IL-6 in cultured cells , 2008, Journal of Molecular Medicine.
[142] A. Guillouzo,et al. Transcripts of ceruloplasmin but not hepcidin, both major iron metabolism genes, exhibit a decreasing pattern along the portocentral axis of mouse liver. , 2008, Biochimica et biophysica acta.
[143] F. Carvalho,et al. Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPα , 2008, Blood.
[144] N. Andrews,et al. The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression. , 2008, Cell metabolism.
[145] J. Abkowitz,et al. A Heme Export Protein Is Required for Red Blood Cell Differentiation and Iron Homeostasis , 2008, Science.
[146] Clara Camaschella,et al. Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis. , 2008, Blood.
[147] 仁科 惣治. Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription , 2008 .
[148] E. Valore,et al. Posttranslational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin. , 2008, Blood cells, molecules & diseases.
[149] K. Okita,et al. Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription. , 2008, Gastroenterology.
[150] T. Ganz,et al. Soluble hemojuvelin is released by proprotein convertase-mediated cleavage at a conserved polybasic RNRR site. , 2008, Blood cells, molecules & diseases.
[151] B. Beutler,et al. The Mask Mutation Identifies TMPRSS6 as an Essential Suppressor of Hepcidin Gene Expression, Required for Normal Uptake of Dietary Iron. , 2007 .
[152] D. Harrison-Findik. Role of alcohol in the regulation of iron metabolism. , 2007, World journal of gastroenterology.
[153] William C. Florence,et al. Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis , 2007, Journal of leukocyte biology.
[154] T. Ganz,et al. Effects of plasma transfusion on hepcidin production in human congenital hypotransferrinemia , 2007, Haematologica.
[155] S. Goh,et al. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin , 2007, Nature Medicine.
[156] Richard F Hurrell,et al. Nutritional iron deficiency , 2007, The Lancet.
[157] Yin Xia,et al. Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. , 2007, The Journal of clinical investigation.
[158] V. Nizet,et al. Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). , 2007, The Journal of clinical investigation.
[159] W. Sundquist,et al. The molecular mechanism of hepcidin-mediated ferroportin down-regulation. , 2007, Molecular biology of the cell.
[160] Andrew Pollock,et al. The flatiron mutation in mouse ferroportin acts as a dominant negative to cause ferroportin disease. , 2007, Blood.
[161] T. Ganz,et al. Liver iron concentrations and urinary hepcidin in beta-thalassemia. , 2007, Haematologica.
[162] N. Andrews,et al. Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation. , 2007, Blood.
[163] Mayka Sanchez,et al. Iron-regulatory proteins limit hypoxia-inducible factor-2α expression in iron deficiency , 2007, Nature Structural &Molecular Biology.
[164] V. Subramaniam,et al. Targeted disruption of the hepatic transferrin receptor 2 gene in mice leads to iron overload. , 2007, Gastroenterology.
[165] G. Musci,et al. Evidence for the multimeric structure of ferroportin. , 2007, Blood.
[166] C. Enns,et al. Transferrin receptor 2: evidence for ligand-induced stabilization and redirection to a recycling pathway. , 2007, Molecular biology of the cell.
[167] Y. Kohgo,et al. Hepcidin is down-regulated in alcohol loading. , 2007, Alcoholism, clinical and experimental research.
[168] K. Hasegawa,et al. Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients. , 2007, Free radical biology & medicine.
[169] K. Kowdley. Alcohol intake and iron overload: Another role for hepcidin? , 2007, Hepatology.
[170] E. Neufeld,et al. Urinary hepcidin in congenital chronic anemias , 2007, Pediatric blood & cancer.
[171] Yi Fang Liu,et al. Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. , 2006, Blood.
[172] Christian Trautwein,et al. STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo. , 2007, Gastroenterology.
[173] M. Kaito,et al. Hepcidin Expression in the Liver: Relatively Low Level in Patients with Chronic Hepatitis C , 2007, Molecular medicine.
[174] M. Hentze,et al. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. , 2007, Blood.
[175] M. Wessling-Resnick,et al. Belgrade rats display liver iron loading. , 2006, The Journal of nutrition.
[176] T. Ganz,et al. Suppression of hepcidin during anemia requires erythropoietic activity. , 2006, Blood.
[177] M. Akabas,et al. Identification of an Intestinal Folate Transporter and the Molecular Basis for Hereditary Folate Malabsorption , 2006, Cell.
[178] N. Andrews,et al. Interleukin-6 induces hepcidin expression through STAT3. , 2006, Blood.
[179] N. Andrews,et al. Hereditary Hemochromatosis Protein, HFE, Interaction with Transferrin Receptor 2 Suggests a Molecular Mechanism for Mammalian Iron Sensing* , 2006, Journal of Biological Chemistry.
[180] Y. Le Marchand-Brustel,et al. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. , 2006, Gastroenterology.
[181] M. Linder,et al. Release of iron from ferritin requires lysosomal activity. , 2006, American journal of physiology. Cell physiology.
[182] S. Vaulont,et al. Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis. , 2006, Blood.
[183] J. Gollan,et al. Alcohol Metabolism-mediated Oxidative Stress Down-regulates Hepcidin Transcription and Leads to Increased Duodenal Iron Transporter Expression* , 2006, Journal of Biological Chemistry.
[184] S. Rivella,et al. mRNA expression of iron regulatory genes in β‐thalassemia intermedia and β‐thalassemia major mouse models , 2006 .
[185] C. Beaumont,et al. Wild-type and mutant ferroportins do not form oligomers in transfected cells. , 2006, The Biochemical journal.
[186] M. Knutson,et al. The Iron Efflux Protein Ferroportin Regulates the Intracellular Growth of Salmonella enterica , 2006, Infection and Immunity.
[187] Raymond T Chung,et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression , 2006, Nature Genetics.
[188] N. Andrews,et al. Chronic hepcidin induction causes hyposideremia and alters the pattern of cellular iron accumulation in hemochromatotic mice. , 2006, Blood.
[189] K. Yeh,et al. Iron Imports. V. Transport of iron through the intestinal epithelium. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[190] A. Waring,et al. The N‐terminus of Hepcidin is Essential for Its Interaction with Ferroportin: Structure‐Function Study , 2005, Blood.
[191] A. Camus,et al. Hepcidins in amphibians and fishes: Antimicrobial peptides or iron-regulatory hormones? , 2006, Developmental and comparative immunology.
[192] S. Rivella,et al. mRNA expression of iron regulatory genes in beta-thalassemia intermedia and beta-thalassemia major mouse models. , 2006, American journal of hematology.
[193] S. Biffo,et al. Ferroportin is a monomer in vivo in mice. , 2006, Blood cells, molecules & diseases.
[194] T. Ganz,et al. Hepcidin and iron-loading anemias. , 2006, Haematologica.
[195] A. Donovan,et al. Comparative studies of duodenal and macrophage ferroportin proteins. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[196] E. Nečas,et al. Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis. , 2006, Physiological research.
[197] Xiaoling Xu,et al. A Role of Smad4 in Iron Metabolism through the Positive Regulation of Hepcidin Expression , 2022 .
[198] J. Sarkar,et al. Unexpected role of ceruloplasmin in intestinal iron absorption. , 2005, Cell metabolism.
[199] S. Rivella,et al. Exploring the Role of Hepcidin, an Antimicrobial and Iron Regulatory Peptide, in Increased Iron Absorption in β‐Thalassemia , 2005, Annals of the New York Academy of Sciences.
[200] N. Andrews,et al. Cybrd1 (duodenal cytochrome b) is not necessary for dietary iron absorption in mice. , 2005, Blood.
[201] V. Subramaniam,et al. Prohepcidin localises to the Golgi compartment and secretory pathway in hepatocytes. , 2005, Journal of hepatology.
[202] P. Højrup,et al. Identification of the receptor scavenging hemopexin-heme complexes. , 2005, Blood.
[203] T. Ganz,et al. Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. , 2005, Blood.
[204] C. Vulpe,et al. Identification of an Intestinal Heme Transporter , 2005, Cell.
[205] W. Stremmel,et al. Iron Stores Modulate Hepatic Hepcidin Expression by an HFE-Independent Pathway , 2005, Digestion.
[206] S. Arber,et al. Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload. , 2005, The Journal of clinical investigation.
[207] G. Pinkus,et al. A mouse model of juvenile hemochromatosis. , 2005, The Journal of clinical investigation.
[208] V. Viprakasit,et al. Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. , 2005, Blood.
[209] T. Ganz,et al. Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels, and hepatic function. , 2005, Blood.
[210] D. Haile,et al. Functional consequences of ferroportin 1 mutations. , 2005, Blood cells, molecules & diseases.
[211] T. Ganz,et al. Hepcidin in iron overload disorders. , 2005, Blood.
[212] A. Donovan,et al. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. , 2005, Cell metabolism.
[213] E. Beutler,et al. Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features. , 2005, Blood cells, molecules & diseases.
[214] T. Ganz,et al. Hepcidin is decreased in TFR2 hemochromatosis. , 2005, Blood.
[215] W. Stremmel,et al. Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes. , 2005, Gastroenterology.
[216] M. Burritt,et al. Liver Hepcidin mRNA Correlates With Iron Stores, but Not Inflammation, in Patients With Chronic Hepatitis C , 2005, Journal of clinical gastroenterology.
[217] T. Ganz,et al. Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin. , 2005, Blood.
[218] J. Said,et al. Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis. , 2005, Blood.
[219] A. Pietrangelo. The ferroportin disease , 2014, Clinical liver disease.
[220] Jerry Kaplan,et al. Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization , 2004, Science.
[221] C. Enns,et al. Diferric transferrin regulates transferrin receptor 2 protein stability. , 2004, Blood.
[222] M. Wessling-Resnick,et al. Regulation of transferrin receptor 2 protein levels by transferrin. , 2004, Blood.
[223] S. Cherukuri,et al. Anemia and impaired stress-induced erythropoiesis in aceruloplasminemic mice. , 2004, Blood cells, molecules & diseases.
[224] S. Fairweather-Tait. Iron nutrition in the UK: getting the balance right , 2004, Proceedings of the Nutrition Society.
[225] Elizabeta Nemeth,et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. , 2004, The Journal of clinical investigation.
[226] J. Jelinek,et al. Disruption of ferroportin 1 regulation causes dynamic alterations in iron homeostasis and erythropoiesis in polycythaemia mice , 2004, Development.
[227] G. Grimber,et al. Functional differences between hepcidin 1 and 2 in transgenic mice. , 2004, Blood.
[228] H. Tsukamoto,et al. Localization of iron metabolism-related mRNAs in rat liver indicate that HFE is expressed predominantly in hepatocytes. , 2004, Blood.
[229] S. Rivella,et al. Decreased hepcidin mRNA expression in thalassemic mice , 2004, British journal of haematology.
[230] Marie-Pierre Dubé,et al. Mutations in HFE2 cause iron overload in chromosome 1q–linked juvenile hemochromatosis , 2004, Nature Genetics.
[231] J. Sarkar,et al. Role of Ceruloplasmin in Macrophage Iron Efflux during Hypoxia* , 2003, Journal of Biological Chemistry.
[232] W. Stremmel,et al. Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to the serum transferrin saturation and to non-transferrin-bound iron. , 2003, Blood.
[233] L. Powell,et al. Hemochromatosis and alcoholic liver disease. , 2003, Alcohol.
[234] J. Gallant,et al. Identification and expression analysis of hepcidin-like antimicrobial peptides in bony fish. , 2003, Developmental and comparative immunology.
[235] N. Andrews,et al. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis , 2003, Nature Genetics.
[236] J. Cook,et al. The quantitative assessment of body iron. , 2003, Blood.
[237] Elizabeta Nemeth,et al. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. , 2003, Blood.
[238] D. Purdie,et al. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis , 2003, The Lancet.
[239] D. Girelli,et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis , 2003, Nature Genetics.
[240] S. Kaufmann,et al. Correction of the Iron Overload Defect in β-2-Microglobulin Knockout Mice by Lactoferrin Abolishes Their Increased Susceptibility to Tuberculosis , 2002, The Journal of experimental medicine.
[241] L. Silengo,et al. Enhanced splenomegaly and severe liver inflammation in haptoglobin/hemopexin double-null mice after acute hemolysis. , 2002, Blood.
[242] W. Sly,et al. Decreased liver hepcidin expression in the Hfe knockout mouse. , 2002, Blood cells, molecules & diseases.
[243] Gaël Nicolas,et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. , 2002, The Journal of clinical investigation.
[244] M. Hentze,et al. Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: Implications for regulation and cellular function , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[245] C. Beaumont,et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[246] D. Belchis,et al. Vibrio vulnificus septicemia in a patient with the hemochromatosis HFE C282Y mutation. , 2009, Archives of pathology & laboratory medicine.
[247] P. Gros,et al. Characterization of the iron transporter DMT1 (NRAMP2/DCT1) in red blood cells of normal and anemic mk/mk mice. , 2001, Blood.
[248] T. Rouault,et al. Association of pulmonary tuberculosis with increased dietary iron. , 2001, The Journal of infectious diseases.
[249] T. Bergmann,et al. Multiple hepatic abscesses due to Yersinia enterocolitica infection secondary to primary haemochromatosis. , 2001, Scandinavian journal of gastroenterology.
[250] C. Beaumont,et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[251] Bruno Turlin,et al. A New Mouse Liver-specific Gene, Encoding a Protein Homologous to Human Antimicrobial Peptide Hepcidin, Is Overexpressed during Iron Overload* , 2001, The Journal of Biological Chemistry.
[252] Christina H. Park,et al. Hepcidin, a Urinary Antimicrobial Peptide Synthesized in the Liver* , 2001, The Journal of Biological Chemistry.
[253] M. Höpfner,et al. Yersinia enterocolitica Infection with Multiple Liver Abscesses Uncovering a Primary Hemochromatosis , 2001, Scandinavian journal of gastroenterology.
[254] S. Moestrup,et al. Identification of the haemoglobin scavenger receptor , 2001, Nature.
[255] Peter Schulz-Knappe,et al. LEAP‐1, a novel highly disulfide‐bonded human peptide, exhibits antimicrobial activity , 2000, FEBS letters.
[256] N. Andrews,et al. The molecular defect in hypotransferrinemic mice. , 2000, Blood.
[257] S. Abboud,et al. A Novel Mammalian Iron-regulated Protein Involved in Intracellular Iron Metabolism* , 2000, The Journal of Biological Chemistry.
[258] A. Brownlie,et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter , 2000, Nature.
[259] R J Simpson,et al. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. , 2000, Molecular cell.
[260] A. West,et al. The hemochromatosis protein HFE competes with transferrin for binding to the transferrin receptor. , 1999, Journal of molecular biology.
[261] J. Gitlin,et al. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[262] P. Gros,et al. Cellular and subcellular localization of the Nramp2 iron transporter in the intestinal brush border and regulation by dietary iron. , 1999, Blood.
[263] Gregory J. Anderson,et al. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse , 1999, Nature Genetics.
[264] N. Andrews,et al. Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[265] N. Andrews,et al. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene , 1997, Nature genetics.
[266] Stephan Nussberger,et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter , 1997, Nature.
[267] R. Crystal. Managed care for viruses , 1997, Nature Medicine.
[268] R. MacGillivray,et al. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[269] C. Finch,et al. Regulators of iron balance in humans. , 1994, Blood.
[270] M. Garrick,et al. Transferrin and the transferrin cycle in Belgrade rat reticulocytes. , 1993, The Journal of biological chemistry.
[271] T. R. Dutson,et al. Meat and Health , 2023, AMA Journal of Ethics.
[272] M. Cazzola,et al. Iron balance in thalassemia. , 1989, Progress in clinical and biological research.
[273] C. Craven,et al. Tissue distribution and clearance kinetics of non-transferrin-bound iron in the hypotransferrinemic mouse: a rodent model for hemochromatosis. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[274] N. Kaufman,et al. An electron microscopic study of heme uptake by rat duodenum. , 1982, Laboratory investigation; a journal of technical methods and pathology.
[275] D. Weatherall,et al. IRON ABSORPTION AND LOADING IN β-THALASSÆMIA INTERMEDIA , 1979, The Lancet.
[276] M. Worwood,et al. Ferritin in serum. Clinical and biochemical implications. , 1975, The New England journal of medicine.
[277] G. M. Addison,et al. Ferritin in serum. , 1973, Lancet.
[278] W. Crosby. Intestinal response to the body's requirement for iron; control of iron absorption. , 1969, JAMA.
[279] T. Bothwell,et al. Body iron excretion in man: a collaborative study. , 1968, The American journal of medicine.
[280] B. Creamer. The turnover of the epithelium of the small intestine. , 1967, British medical bulletin.